EMEA-Marktzulassung für ChondroCelect!
Seite 1 von 1 Neuester Beitrag: 15.12.17 13:23 | ||||
Eröffnet am: | 26.06.09 14:29 | von: windy k.tor | Anzahl Beiträge: | 7 |
Neuester Beitrag: | 15.12.17 13:23 | von: pitri007 | Leser gesamt: | 4.508 |
Forum: | Börse | Leser heute: | 1 | |
Bewertet mit: | ||||
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted its first positive opinion for an advanced therapy medicinal product, recommending that ChondroCelect, from TiGenix NV, be granted a marketing authorisation. The CHMP adopted its opinion on the basis of a draft opinion prepared by the Agency’s new Committee for Advanced Therapies (CAT).
http://www.emea.europa.eu/pdfs/human/press/pr/39721509en.pdf